Danish biotech Zealand Pharma is opening a Boston research hub to speed obesity drug discovery and expects to hire about 50–100 staff.

Vertex’s kidney‑disease candidate povetacicept met primary and secondary Phase 3 goals in a Week 36 interim readout, clearing an accelerated path toward an FDA filing this month.

Korro Bio announced an ~$85M private placement to extend its cash runway into late 2028 after its KRRO‑110 trial fell short and staffing was cut.

Cognito Therapeutics raised $105M to push Spectris, its at‑home light‑and‑sound therapy for Alzheimer’s, closer to an FDA filing as pivotal trial data arrive.

After 15 years, Dr. Kevin Tabb will step down from Beth Israel Lahey Health within a year as the system launches a national search and readies a Dana‑Farber cancer hospital.

Five Boston‑area companies landed on LexisNexis’ Top 100 Global Innovators list — the region’s strongest showing yet across biotech and consumer tech.

Ginkgo Bioworks is pivoting from benches to sell AI‑powered lab robots and a cloud lab out of its Boston Seaport hub after years of losses. The company hopes automation will revive revenue.

ARPA‑H is directing new program money into Boston’s Investor Catalyst Hub — backing lymphatic therapies and tear‑based monitoring — even as state leaders press for clarity after a stop‑work notice.

Watertown‑based Disc Medicine cut about 20% of its staff after the FDA issued a Complete Response Letter for bitopertin; the company says a Phase 3 readout now dictates next steps.

Logan Airport has rolled out TSA PreCheck Touchless ID in three terminals, letting opted-in PreCheck flyers verify identity with a facial scan while privacy questions linger.

Boston startups raised about $922M in February and added two unicorns, led by AI, fintech and cybersecurity rounds that kept local venture activity hot.

A Penn–Harvard team embedded an ultrathin electronic mesh into pancreatic organoids, boosting cell maturity and glucose responsiveness.

Mass General Brigham teams pair gene research with a validated Brain Care Score that studies link to sizable reductions in dementia risk.